144 related articles for article (PubMed ID: 9410209)
1. [Characteristics of Ca(2+)-induced response of erythrocytes in patients with lung cancer during antineoplastic chemotherapy].
Petrova IV; Stepovaia EA; Sokolova IB; Gol'dberg VE; Chasovskikh NIu; Koreshkova KG; Bazhenova NG; Kolosova MV; Baskakov MB; Novitskiĭ VV; Medvedev MA
Biull Eksp Biol Med; 1997 Aug; 124(8):195-8. PubMed ID: 9410209
[No Abstract] [Full Text] [Related]
2. [Dry extract of Scutellaria baicalensis as a hemostimulant in antineoplastic chemotherapy in patents with lung cancer].
Gol'dberg VE; Ryzhakov VM; Matiash MG; Stepovaia EA; Boldyshev DA; Litvinenko VI; Dygaĭ AM
Eksp Klin Farmakol; 1997; 60(6):28-30. PubMed ID: 9460593
[TBL] [Abstract][Full Text] [Related]
3. [The effect of antitumor chemotherapy on the lipid spectrum of the erythrocyte membranes in lung cancer patients].
Novitskiĭ VV; Stepovaia EA; Bazhenova NG; Gol'dberg VE; Kolosova MV; Saprykina EV; Sokolova IB; Koreshkova KG; Bulavina IaV
Eksp Klin Farmakol; 1999; 62(1):56-9. PubMed ID: 10198770
[TBL] [Abstract][Full Text] [Related]
4. [Radioimmunologic evaluation of the prognosis and effective therapy of patients with small cell lung cancer].
Ausekar BP6 ; Smirnova KD; Gromova NV; Perevodchikova NI
Med Radiol (Mosk); 1985 Nov; 30(11):18-20. PubMed ID: 2999553
[TBL] [Abstract][Full Text] [Related]
5. [Polychemotherapy using methotrexate, adriamycin, cyclophosphamide and CCNU (MACC) in patients with advanced adenocarcinoma and large cell carcinoma of the lung].
Karnicka-Młodkowska H; Jassem J; Mierzewski P; Słupek A; Mierzwa W; Decker E; Prokop A; Krawczyk K; Kowal E; Firlik M
Pneumonol Pol; 1986 Dec; 54(12):546-51. PubMed ID: 3035511
[No Abstract] [Full Text] [Related]
6. Surgery for cure of small cell bronchial carcinoma (SCLC) at early stages and postoperative combined modality treatment.
Karrer K; Denck H; Karnicka-Mlodkowska H; Drings P; Erzen J; Salzer GM;
J Chemother; 1989 Jul; 1(4 Suppl):1207-8. PubMed ID: 16312836
[No Abstract] [Full Text] [Related]
7. [Treatment of lung cancer--state of the art in 2000].
Nakanishi Y; Inoue K; Hara N
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1247-52. PubMed ID: 10945023
[TBL] [Abstract][Full Text] [Related]
8. [Specific features of erythrocyte membranes and metabolism in patients with lung cancer].
Stepovaia EA; Novitskiĭ VV; Goldberg VE; Riazantseva NV; Tkachenko SB; Kolosova MV
Vopr Onkol; 2004; 50(1):63-7. PubMed ID: 15088524
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics Ca2+-induced hyperpolarization in erythrocytes from patients with tumors of various localization].
Petrova IV; Sokolova IB; Stepovaia EA; Kolosova MV; Koriukin VI; Gol'dberg VE; Baskakov MB; Medvedev MA; Novitskiĭ VV
Biull Eksp Biol Med; 1999 Jan; 127(1):77-80. PubMed ID: 10190012
[No Abstract] [Full Text] [Related]
10. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
Yuen AR; Fuks JZ; Ettinger DS; Chang AY; Ruckdeschel JC; Phan SC; Blum RH
Cancer J Sci Am; 2000; 6(1):34-9. PubMed ID: 10696737
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of treatment of recurrent small-cell lung cancer.
Hosp Med; 1999 Mar; 60(3):220. PubMed ID: 10476252
[No Abstract] [Full Text] [Related]
12. Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.
Athanassiades P; Lagoudis M; Kostis E
J Chemother; 1989 Jul; 1(4 Suppl):1205-6. PubMed ID: 16312835
[No Abstract] [Full Text] [Related]
13. The cigarette burden (measured by the number of pack-years smoked) negatively impacts the response rate to platinum-based chemotherapy in lung cancer patients.
Duarte RL; Luiz RR; Paschoal ME
Lung Cancer; 2008 Aug; 61(2):244-54. PubMed ID: 18243408
[TBL] [Abstract][Full Text] [Related]
14. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
[TBL] [Abstract][Full Text] [Related]
15. [Long-term results of small cell lung cancer treated by surgery combined with postoperative chemotherapy: a report of 65 patients].
Zhang X; Sun Y; Huang J
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):137-9. PubMed ID: 10743080
[TBL] [Abstract][Full Text] [Related]
16. [Polychemotherapeutic experience in oat-cell type lung tumors].
Ruiz Alcantarilla P; Justo Alpañés E; Sánchez Cousteau JA; Garrido Peralta M
Rev Clin Esp; 1984 Jan; 172(1):47-50. PubMed ID: 6324301
[No Abstract] [Full Text] [Related]
17. [Postoperative adjuvant treatment for non-small cell lung cancer].
Ichinose Y
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2470-4. PubMed ID: 12506468
[TBL] [Abstract][Full Text] [Related]
18. Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer.
Green MR
J Clin Oncol; 2008 Jul; 26(19):3112-3. PubMed ID: 18591551
[No Abstract] [Full Text] [Related]
19. [Effects, possibilities and limits. Cytostatic therapy of small cell and non-small cell lung cancer].
Bergman B
Lakartidningen; 1997 Apr; 94(18):1702, 1707-10. PubMed ID: 9182178
[No Abstract] [Full Text] [Related]
20. Serum endostatin levels in patients with lung carcinoma.
Swidzińska E; Ossolińska M; Naumnik W; Trojan S; Chyczewska E
Rocz Akad Med Bialymst; 2005; 50():197-200. PubMed ID: 16358965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
